Eculizumab shows promise in treating refractory generalized myasthenia gravis (gMG)
Newly reported data from a clinical trial led by a UNC School of Medicine researcher show that eculizumab may be helpful in treating treating refractory generalized myasthenia gravis (gMG), an extremely rare neuromuscular ...
Jul 19, 2016
0
0